Chemoprophylaxis using hydroxychloroquine against Coronavirus infection is recommended to safeguard the very backbone of the medical system, the healthcare professionals. To ensure that this move does not inflict a feeling of false security, the Indian Council of Medical Research (ICMR) has issued advisory and recommendations on the use of hydroxychloroquine in COVID-19. The following article contains details of the issued advisory. Both in vitro and in vivo studies have found hydroxychloroquine to be efficacious in combating COVID-19.
Currently, the available evidence supports its use in the treatment and prophylaxis of this deadly disease. The use of hydroxychloroquine for prophylaxis of COVID-19 in high-risk populations is recommended by the National Taskforce for COVID-19 constituted by the Indian Council of Medical Research. The recommendations are as follows: Eligible Individuals:…
